IN2013MU02986A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02986A
IN2013MU02986A IN2986MU2013A IN2013MU02986A IN 2013MU02986 A IN2013MU02986 A IN 2013MU02986A IN 2986MU2013 A IN2986MU2013 A IN 2986MU2013A IN 2013MU02986 A IN2013MU02986 A IN 2013MU02986A
Authority
IN
India
Prior art keywords
agents
group
sodium
gum
sterculiafoetida
Prior art date
Application number
Other languages
English (en)
Inventor
Vijay Deorao Dr Gulkari
Rahul Harishchandra Dr Kasliwal
Shashikant Sadashivrao Burpute
Shailendra Shivaji Dr Gurav
Gurav Nilambari Shailendra Mrs
Original Assignee
Vijay Deorao Dr Gulkari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vijay Deorao Dr Gulkari filed Critical Vijay Deorao Dr Gulkari
Priority to IN2986MU2013 priority Critical patent/IN2013MU02986A/en
Publication of IN2013MU02986A publication Critical patent/IN2013MU02986A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
IN2986MU2013 2013-09-13 2013-09-13 IN2013MU02986A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2986MU2013 IN2013MU02986A (enExample) 2013-09-13 2013-09-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2986MU2013 IN2013MU02986A (enExample) 2013-09-13 2013-09-13

Publications (1)

Publication Number Publication Date
IN2013MU02986A true IN2013MU02986A (enExample) 2015-10-09

Family

ID=54397044

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2986MU2013 IN2013MU02986A (enExample) 2013-09-13 2013-09-13

Country Status (1)

Country Link
IN (1) IN2013MU02986A (enExample)

Similar Documents

Publication Publication Date Title
MX392839B (es) Liberacion autorregulada de ingrediente farmaceutico activo.
MX2016006053A (es) Compuestos selectivos de peptido yy (pyy) y usos de los mismos.
EA201690962A1 (ru) Составы
NZ735575A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
PT2310356E (pt) Derivados de adamantildiamida e a sua utilização
TN2011000172A1 (en) Therapeutic antiviral peptides
PH12015501993B1 (en) Pyrazole-amide compound and medicinal uses therefor
MY183312A (en) Pharmaceutical formulation
CO6480932A2 (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida.
MY187718A (en) Pharmaceutical formulations
MX343689B (es) Formulaciones combinadas de darunavir.
NZ757929A (en) Benzoazepine analogs as inhibiting agents for bruton’s tyrosine kinase
EA202090542A1 (ru) Высококонцентрированные лекарственные формы придопидина
MY174005A (en) Swallowable n-acetylcysteine tablets
TN2015000135A1 (en) Modified release formulations for oprozomib
EP4560024A3 (en) Deuterated analogs of d-serine and uses thereof
MX341976B (es) Formulaciones de darunavir.
EA201791009A1 (ru) Композиции, содержащие циклоспорин
EA201490166A1 (ru) Фторированные арилалкиламинокарбоксамидные производные
MY169266A (en) Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide
MX2020007326A (es) Regimen de dosificacion de siponimod.
ZA202107580B (en) Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4- methoxybenzylsulphone with enhanced stability and bioavailability
IN2013MU02986A (enExample)
BR112017019364A2 (pt) dispersões sólidas
IN2013MU02985A (enExample)